{"SPADE_UN_11012": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2011/0159022 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2011_0159022_A1", "Patent Type": "Patent Application", "Publication Date": "2011-6-30", "Family Info": "CA2728459A1,CN102123731A,EP2296697A1,WO2009153463A1", "Patent Title": "Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine.", "Abstract": "A peptide derived from the Midkine protein, comprising at least one CD4+ T or CD8+ T epitope restricted by the HLA molecules predominant in the Caucasian population, or a polynucleotide encoding said peptide, as an anticancer vaccine or as a reagent for immunomonitoring of the cellular response against Midkine over the course of a cancer or of an anticancer treatment."}], "Sequence Information": {"SPADE ID": "SPADE_UN_11012", "Sequence": "EKKYFAATQFEPLAARL", "Sequence Length": 17, "Peptide Name": "Sequence 37 from Patent US 20110159022", "Source": "Synthetic construct", "Biological Activity": ["Anticancer"], "Frequent Amino Acids": "AEF", "Absent Amino Acids": "CDGHIMNOSUVW", "Basic Residues": 3, "Acidic Residues": 2, "Hydrophobic Residues": 10, "Polar Residues": 10, "Positive Residues": 3, "Negative Residues": 2, "Mass": 1983.27, "PI": 8.59, "Net Charge": 1, "Hydrophobicity": -0.35, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_14424", "Similarity": 1.0, "Sequence": "IEEIEKKIEEIEKKIEEIEKKIEEIEKKIEEIEKK"}, {"SPADE_ID": "SPADE_N_11060", "Similarity": 0.8, "Sequence": "LAAKLTKAATKLTAALTKLAAALT"}, {"SPADE_ID": "SPADE_UN_22305", "Similarity": 0.8, "Sequence": "LAAKLTKAAKLTAALTKLAAALTAAAT"}]}}}